Herpes Zoster (Shingles) - Pipeline Review, H2 2015

1
Herpes Zoster (Shingles) - Pipeline Review, H2
2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Scope
• The report provides a snapshot of the global
  therapeutic landscape of Herpes Zoster (Shingles)
  
• The report reviews key pipeline products under
  drug profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities
• The report reviews key players involved in the
  therapeutics development for Herpes Zoster
  (Shingles) and enlists all their major and minor
  projects
• The report summarizes all the dormant and
  discontinued pipeline projects
• A review of the Herpes Zoster (Shingles) products
  under development by companies and
  universities/research institutes based on
  information derived from company and
  industry-specific sources
• Pipeline products coverage based on various
  stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• A detailed assessment of monotherapy and
  combination therapy pipeline projects
• Coverage of the Herpes Zoster (Shingles) pipeline
  on the basis of target, MoA, route of
  administration and molecule type
• Latest news and deals relating related to
  pipeline products
• Read More At http//www.researchbeam.com/herpes-
  zoster-shingles-pipeline-review-h2-2015-market

3


Table of Content
Table of ContentsTable of Contents 2List of
Tables 4List of Figures 5Introduction 6Global
Markets Direct Report Coverage 6Herpes Zoster
(Shingles) Overview 7Therapeutics Development
8Pipeline Products for Herpes Zoster (Shingles)
- Overview 8Pipeline Products for Herpes Zoster
(Shingles) - Comparative Analysis 9Herpes Zoster
(Shingles) - Therapeutics under Development by
Companies 10Herpes Zoster (Shingles) - Pipeline
Products Glance 11Late Stage Products
11Clinical Stage Products 12Early Stage
Products 13Unknown Stage Products 14Herpes
Zoster (Shingles) - Products under Development by
Companies 15Herpes Zoster (Shingles) - Companies
Involved in Therapeutics Development 16Astellas
Pharma Inc. 16Beijing Minhai Biotechnology Co.,
Ltd 17Epiphany Biosciences, Inc. 18
4


Report Overview
Reasons to buy - Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies - Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage - Develop strategic initiatives by
understanding the focus areas of leading
companies - Identify and understand important
and diverse types of therapeutics under
development for Herpes Zoster (Shingles) - Plan
mergers and acquisitions effectively by
identifying key players of the most promising
pipeline - Devise corrective measures for
pipeline projects by understanding Herpes Zoster
(Shingles) pipeline depth and focus of Indication
therapeutics - Develop and design in-licensing
and out-licensing strategies by identifying
prospective partners with the most attractive
projects to enhance and expand business potential
and scope - Modify the therapeutic portfolio by
identifying discontinued projects and
understanding the factors that drove them from
pipeline Enquire At http//www.researchbeam.c
om/herpes-zoster-shingles-pipeline-review-h2-2015-
market/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/herpes-zoster-shingles
-pipeline-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com